in a 6-week clinical trial 4 dose regimens of 3'-azido-3'-deoxythymidine ( azt ) , a thymidine analogue with potent anti-viral activity against htlv-iii in vitro , were examined in 19 patients with the acquired immunodeficiency syndrome ( aids ) or aids-related complex ( arc ) .
C0043474
azt
C0001175
aids